Navigation Links
NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
Date:10/16/2007

LAWRENCE, Mass., Oct. 16 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, announced plans to release its financial results for the third quarter 2007 on Friday, November 2, 2007 before the opening of the financial markets.

NxStage will also host a conference call at 10:00 a.m. Eastern Time on November 2, 2007 to discuss its third quarter 2007 financial results. To listen to the conference call, please dial 800.638.5495 for domestic callers and 617.614.3946 for international callers. The passcode is 84751301. A replay of the conference call will be available two hours after the start of the call through November 16, 2007 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 30934295. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://www.nxstage.com.

About NxStage Medical

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...re-Asia/--ShanghaiBiolaxyannouncedthe,ChineseState...vestigationalnewdrugapplication(IND)foritsoralinsu...totreatdiabetes.ThisIND,approvalallowsBiolaxytoini...sadisordercharacteristicofhighbloodglucoseandpoor,...severemicro-and,macro-vasculardiseases,lossofvisio...
(Date:11/24/2009)...RONTO,Nov.24/PRNewswire-FirstCall/-HamiltonThorneL...providerofadvancedlasersystemsandinstrumentsforthe...ortedoperationalandfinancialresultsforthethirdquar...evenuewas$1.46millioncomparedwith$1.43millioninQ32....1percentinQ3,2008,-Netlossreducedto$148,000compar...
(Date:11/24/2009)...RNewswire/--HealthRoboticstodayannounced,thatithas...,investors.ThisrecentlyformedToronto-basedcompanyw...dwillmarket,install,andsupport,HealthRobotics,i.v....aryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),an...ssistanceonan"asneeded,basis"toitsstrategicpartner...
(Date:11/23/2009)... In a provocative new study, a University of Utah...ions the major cause of global warming cannot be...r society builds the equivalent of one new nuclear...t there will be any substantial near-term departur...oxide emission rates," says the new paper by Tim G...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...TENTS ISSUED IN U.S. AND EUROPE FOR TECHNOLOGY USE...CULAR DIAGNOSTIC PRODUCT LINE , , DENVER, Jan. 20...: CONX), a worldwide developer and marketer of dia...o new patents for technology to which Corgenix hol... Japan. The technology is incorporated in the com...
...L, Wash., Jan. 20 SCOLR Pharma, Inc. (Amex: DDD...ministration (FDA) has issued a Complete Response ...NDA) for pseudoephedrine. The application, filed ...et a 120 mg 12 hour pseudoephedrine tablet based o...(R)) platform. , , The Complete Response letter ...
...SEPH, Mich., Jan. 20 GeneGo, Inc., the leading sy...the Department of Energy,s Pacific Northwest Nati...eGo Center of Excellence. PNNL researchers will h...ata analysis suite, training and advanced support....ess complex national challenges in fundamental sci...
Other Biology Technology:Corgenix Receives Two Additional Patents on AtherOx(R) Technology 2Corgenix Receives Two Additional Patents on AtherOx(R) Technology 3FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 2FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 3Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence 2
(Date:11/24/2009)...en prescribed by traditional healers in Brazil to ...ch pain to fever and flu. , Now for the first tim...ble to scientifically prove the pain relieving pro...azilian mint. , Testing this ancient South Americ...la Rocha was able to show that when prepared as a ...
(Date:11/24/2009)...ors to understanding how sounds associated with Na...al or if they hear it at all. , The same type o...uses to detect flaws in the space shuttle,s behemo...o peek inside the giant head of a whale. The scans... of a whale,s hearing anatomy using a breakthrough...
(Date:11/24/2009)...abby arteries from collapsing have been true life-...longer needed -- once the arteries are strengthene...d no choice but to leave them in place. , Prof. ...nt of Biomedical Engineering has developed a new p...ere they,re needed, then dissolves. , "Our new c...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2A coating for life 2Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 1Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 2Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 3Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 4Growing cartilage from stem cells 10456 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 2Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 3
..., but many dinosaurs apparently had genomes no lar...ientists who,ve linked bone cell and genome size a...anding to gauge the genome sizes of 31 species of ...be measured from the fossil record. , The resea...f Reading, were led by Chris Organ and Scott V. Ed...
...hat give rise to a rare genetic disease, genetics ...hway that may have a broader role during human dev...on and autism. , An international team of researc...lia deLange syndrome (CdLS), a multisystem genetic...hildren. The disease varies from milder to more se...
...tion in mice results in an enhanced long-term memo...of the journal Cell, published by Cell Press. Thes...elopment of a drug to treat memory loss, according...ene that normally increases levels of a natural me...ive version of this gene showed improved performan...
Other Biology News:Despite their heft, many dinosaurs had surprisingly tiny genomes 2Gene found for rare disorder may reveal new pathway in mental retardation 2Mutation improves memory, may lead to memory-enhancing pill 2Mutation improves memory, may lead to memory-enhancing pill 3
Mouse Anti-Vancomycin Monoclonal Antibody, Unconjugated, Clone 2G1 from Abcam
Rat Anti-acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Abcam
Anti-Human I-FABP Polyclonal Antibody, Unconjugated from Cell Sciences
ProPrep BAC 960 from Biotech Support Group
Biology Products: